the NL genome project

The NL Genome Project is a local research study looking at the unique genetic makeup of Newfoundland and Labrador to discover better, safer medicines and improve how we treat and prevent diseases.

NL Genome Project Website
Home nlgp 2

newfoundland & labrador genome project

Sequence Bio’s NL Genome Project is researching the genetic makeup of 10,000 volunteering participants in Newfoundland and Labrador. By studying our province’s one-of-a-kind DNA and health information, we hope to discover better, safer medicines and improve how we treat and prevent diseases.


Take me to the NL Genome Project site!

Sequence Bio

Improving healthcare and drug discovery here at home

Sequence Bio is committed to benefiting the lives of individuals, families, and communities in Newfoundland and Labrador for generations to come. We’ll share any discoveries from the NL Genome Project with researchers, policy makers, and doctors across the province, and return genetic findings to participants.

By working together, we believe that Newfoundlanders and Labradorians can change lives at home and around the world.

WHY NEWFOUNDLAND AND LABRADOR?

there's nowhere quite like it

Modern drug discovery relies on the right kind of information: real-world patient data that integrates pan-omics with well-characterized phenotypic information. And while this information isn't found everywhere, it is found in Newfoundland and Labrador.

Icon isolated

unique isolated population

Icon desease

high incidence of rare and complex diseases

Icon electronic records

comprehensive health records

Icon family

extended family pedigrees

PARTNERSHIP OPPORTUNITIES

a life-changing approach

We're always looking for exciting partnerships with companies that understand the value of human genetics as a platform for drug discovery and are willing to share our commitment to the people of Newfoundland and Labrador, so get in touch today!


inquire about partnerships

Our Partners
THE SEQUENCE CREW

meet the team

We're a committed team of Newfoundlanders and Labradorians and global experts from a wide range of backgrounds, driven to change the future of healthcare and accelerate the discovery of better, safer medicines and disease treatments. Get to know us a little more by clicking on our photos!

We're hiring, join the team

Chris Gardner

ceo & president

Richard A. Leach PhD

Chief Strategy Officer

Michael S. Phillips PhD

Chief scientific officer

Lynn Healey

Chief Operating & Financial Officer

Dan Brake

Executive Vice President of Technology & Cohort Operations

Jill Van Wart-Hood PhD

vp, business development

Ranjit Randhawa PhD

VP, Research, Data Science & Analytics

Joy Buckle MBA MSc

VP, Policy & Planning

Sean Awalt

VP, Partnership Strategy

Gerry Mugford PhD

Director of research

Fanny Coron

genetic counsellor

Kendra Lane

Chief of Staff

Dave Phillips

director of finance

Alain O'Dea

Director of Security and Infrastructure

Diane Power

Senior Manager, Cohort Operations

ADVISED BY THE BRIGHTEST MINDS

scientific advisory board

Dr. Kathy Hudson

board Chair

Dr. Euan Ashley

Stanford medicine

Dr. Pek Lum

auransa inc.

SEQUENCE BIO LEADERSHIP

board of directors

Chris Gardner

sequence bio

Mark Dobbin

killick capital

Brendan Paddick

columbus capital

John Phillips

klister credit corp

Sequence Bio is conducting research in Newfoundland and Labrador, and doing so in an ethical way is our first priority. Our research efforts require approval by the Health Research Ethics Board (HREB), and the words “believe,” “expect,” “anticipate,” and similar expressions, among others, generally identify our intent and/or objective to undertake additional research in this province. 

Sequence Bio does not share information about planned research studies until they are approved.